886 related articles for article (PubMed ID: 30235451)
1. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X
Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451
[TBL] [Abstract][Full Text] [Related]
2. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine Alleviates Hyperoxia-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation.
Zhang Q; Wu D; Yang Y; Liu T; Liu H
Cell Physiol Biochem; 2017; 42(5):1907-1919. PubMed ID: 28873369
[TBL] [Abstract][Full Text] [Related]
4. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
Yang H; Lv H; Li H; Ci X; Peng L
Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
[TBL] [Abstract][Full Text] [Related]
5. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
Zhang A; Wang S; Zhang J; Wu H
Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
[TBL] [Abstract][Full Text] [Related]
6. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
8. Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via H
Dilxat T; Shi Q; Chen X; Liu X
Aging (Albany NY); 2024 Apr; 16(7):6521-6536. PubMed ID: 38613798
[TBL] [Abstract][Full Text] [Related]
9. NLRX1 knockout aggravates lipopolysaccharide (LPS)-induced heart injury and attenuates the anti-LPS cardioprotective effect of CYP2J2/11,12-EET by enhancing activation of NF-κB and NLRP3 inflammasome.
Zhao G; Wang X; Edwards S; Dai M; Li J; Wu L; Xu R; Han J; Yuan H
Eur J Pharmacol; 2020 Aug; 881():173276. PubMed ID: 32574674
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
11. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of pteryxin on LPS-induced acute lung injury via modulating MAPK/NF-κB pathway and NLRP3 inflammasome activation.
Xuan TQ; Gong G; Du H; Liu C; Wu Y; Bao G; Ma Q; Zhen D
J Ethnopharmacol; 2022 Mar; 286():114924. PubMed ID: 34942323
[TBL] [Abstract][Full Text] [Related]
13. Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation.
Zhang B; Wang B; Cao S; Wang Y; Wu D
Int J Mol Med; 2017 May; 39(5):1111-1118. PubMed ID: 28350048
[TBL] [Abstract][Full Text] [Related]
14. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX
Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
Yang JW; Mao B; Tao RJ; Fan LC; Lu HW; Ge BX; Xu JF
J Cell Mol Med; 2020 Nov; 24(21):12716-12725. PubMed ID: 32977368
[TBL] [Abstract][Full Text] [Related]
16. Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-κB signaling and NLRP3 inflammasome activation.
Peng S; Gao J; Liu W; Jiang C; Yang X; Sun Y; Guo W; Xu Q
Oncotarget; 2016 Dec; 7(49):80262-80274. PubMed ID: 27793052
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M
Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555
[TBL] [Abstract][Full Text] [Related]
18. Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice.
Lei J; Shen Y; Xv G; Di Z; Li Y; Li G
Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):306-313. PubMed ID: 32419528
[TBL] [Abstract][Full Text] [Related]
19. Sepsis-induced acute lung injury in young rats is relieved by calycosin through inactivating the HMGB1/MyD88/NF-κB pathway and NLRP3 inflammasome.
Chen G; Hou Y; Li X; Pan R; Zhao D
Int Immunopharmacol; 2021 Jul; 96():107623. PubMed ID: 33857805
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
